Emotional disability days: Prevalence and predictors

Department of Mental Hygiene, Johns Hopkins University School of Hygiene and Public Health, Baltimore, Md 21205.
American Journal of Public Health (Impact Factor: 4.23). 09/1994; 84(8):1304-7. DOI: 10.2105/AJPH.84.8.1304
Source: PubMed

ABSTRACT This study considered days missed from work or usual activities for emotional reasons associated with a range of specific psychopathologic disorders, psychosocial distress, and persons found to be asymptomatic. Analyses were performed with the presence or absence of emotional disability days as the dependent variable using logistic regression. The effects of specific mental disorders were compared with the effects of chronic physical conditions for labor force participants and for the total population. The odds ratio (and 95% confidence interval) for subjects with major depressive disorder was 27.8 (6.93, 108.96); for panic disorder, 21.1 (2.25, 198.44); and for schizophrenia, 17.8 (1.73, 182.99). Work-place adjustments for persons with psychopathology are encouraged.

Download full-text


Available from: Anthony C Kouzis, Aug 09, 2015
  • Source
    • "MDD contributes 4.4% of the total disability-adjusted life years (Murray and Lopez, 1996; Ustun et al., 2004) and is associated with substantial personal, economic, and social burden (Kessler et al., 2003). For example, individuals with MDD are approximately 28 times more likely to miss workdays or usual activities because of emotional reasons (Kouzis and Eaton, 1994). Despite the high prevalence and burden of MDD, only approximately 60% of individuals receive treatment (Kessler et al., 2003), making it an important public health challenge . "
    [Show abstract] [Hide abstract]
    ABSTRACT: The current study examined demographic and psychosocial factors that predict major depressive disorder (MDD) and comorbid MDD/posttraumatic stress disorder (MDD/PTSD) diagnostic status after Hurricane Katrina, one of the deadliest and costliest hurricanes in the history of the United States. This study expanded on the findings published in the article by Galea, Tracy, Norris, and Coffey (J Trauma Stress 21:357-368, 2008), which examined the same predictors for PTSD, to better understand related and unique predictors of MDD, PTSD, and MDD/PTSD comorbidity. A total of 810 individuals representative of adult residents living in the 23 southernmost counties of Mississippi before Hurricane Katrina were interviewed. Ongoing hurricane-related stressors, low social support, and hurricane-related financial loss were common predictors of MDD, PTSD, and MDD/PTSD, whereas educational and marital status emerged as unique predictors of MDD. Implications for postdisaster relief efforts that address the risk for both MDD and PTSD are discussed.
    The Journal of nervous and mental disease 10/2013; 201(10):841-847. DOI:10.1097/NMD.0b013e3182a430a0 · 1.81 Impact Factor
  • Source
    • "Panic disorder has a negative impact on well-being and on health perception (Katerndahl & Realini, 1997 ; Klerman et al. 1991), and is associated with impaired functioning (Kessler et al. 2006 ; Wittchen et al. 1998) and absence from work (Alonso et al. 2004 ; Kouzis & Eaton, 1994, 1997). In addition, panic disorder may be associated with suicidal ideation and/or attempts (Cougle et al. 2009 ; Goodwin & Roy-Byrne, 2006 ; Lepine et al. 1993 ; Weissman et al. 1989), even if the impact of comorbid disorders on this association is a matter of debate (Hornig & McNally, 1995) and although the evidence that panic disorder causes suicidality remains unclear (Sareen et al. 2005a). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The evidence-based pharmacotherapy of panic disorder continues to evolve. This paper reviews data on first-line pharmacotherapy, evidence for maintenance treatment, and management options for treatment-refractory patients. A Medline search of research on pharmacotherapy was undertaken, and a previous systematic review on the evidence-based pharmacotherapy of panic disorder was updated. Selective serotonin reuptake inhibitors remain a first-line pharmacotherapy of panic disorder, with the serotonin noradrenaline reuptake inhibitor venlafaxine also an acceptable early option. Temporary co-administration of benzodiazepines can be considered. Maintenance treatment reduces relapse rates, but further research to determine optimal duration is needed. For patients not responding to first-line agents several pharmacotherapy options are available, but there is a notable paucity of data on the optimal choice.
    The International Journal of Neuropsychopharmacology 06/2011; 15(3):1-13. DOI:10.1017/S1461145711000800 · 5.26 Impact Factor
  • Source
    • "There appears to be a big difference between depressive symptoms and depressive disorder, suggesting that depressive symptoms do not accurately provide information on depressive disorder. When we look at studies reporting the prevalence of distress in employee samples, figures vary between 12 and 25% (Kouzis and Eaton 1994; Hilton et al. 2008; Bültmann et al. 2005; Virtanen et al. 2007). Since the concept of distress includes depressive symptoms (among other symptoms), and given the similar prevalence figures for distress and depressive symptoms, the conclusion seems justified that depressive symptom scales not only measure symptoms of depressive disorder but often measure what is called distress too. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Mental health problems are associated with sickness absence (SA). The present study aimed at establishing which symptoms-distress, depression, anxiety, or somatization-at which symptom levels were associated with SA frequency and duration. Moreover, a number of possible confounders or effect modifiers were taken into account. A survey was completed by 3,678 employees of a large Dutch telecom company. Symptoms were measured using the Four-Dimensional Symptom Questionnaire (4DSQ). SA data were registered by the company's occupational health service during the 12 months' period following the survey. Poisson regression was used to analyze the number of SA spells (SA frequency). Negative binomial regression was used to analyze the total number of SA days (SA duration). In the bivariate analyses distress, depression, anxiety, and somatization impacted on SA frequency and duration. In the multivariate analyses, anxiety and depression turned out not to be directly associated with SA, suggesting that the effect of anxiety and depression was due to the association between anxiety/depression and distress/somatization. Regarding the SA frequency, the rate ratio for 'subclinical' distress was 1.13 (95% CI 1.03-1.25), for 'clinical' distress 1.26 (1.08-1.47), for 'subclinical' somatization 1.34 (1.23-1.46), and for 'clinical' somatization 1.69 (1.46-1.95). Regarding the SA duration, the count ratio for 'subclinical' distress was 1.15 (95% CI 0.91-1.44), for 'clinical' distress 1.50 (1.04-2.16), for 'subclinical' somatization 1.34 (1.10-1.64), and for 'clinical' somatization 1.45 (1.04-2.03). Somatization and distress are key to understand why depression and anxiety are related to SA.
    International Archives of Occupational and Environmental Health 04/2011; 84(7):825-37. DOI:10.1007/s00420-011-0637-4 · 2.20 Impact Factor
Show more